ID
13577
Beschrijving
Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00093990
Link
https://clinicaltrials.gov/show/NCT00093990
Trefwoorden
Versies (1)
- 17-02-16 17-02-16 -
Houder van rechten
CC BY-NC 3.0
Geüploaded op
17 februari 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Myeloid Leukemia NCT00093990
Eligibility Acute Myeloid Leukemia NCT00093990
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
previous cytotoxic or biologic treatment for aml
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0677881
- UMLS CUI [2]
- C0278947
- UMLS CUI [3]
- C0023467
Beschrijving
acute promyelocytic leukemia (apl)
Datatype
boolean
Alias
- UMLS CUI [1]
- C0023487
Beschrijving
central nervous system leukemia
Datatype
boolean
Alias
- UMLS CUI [1]
- C1332884
Beschrijving
uncontrolled systemic infection
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009488
Beschrijving
uncompensated disseminated intravascular coagulation
Datatype
boolean
Alias
- UMLS CUI [1]
- C0012739
Beschrijving
symptomatic neuropathy of grade 2 or worse
Datatype
boolean
Alias
- UMLS CUI [1]
- C0442874
Beschrijving
known allergy to imidazole drugs.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0020923
Similar models
Eligibility Acute Myeloid Leukemia NCT00093990
- StudyEvent: Eligibility
C0392920 (UMLS CUI [1,2])
C0521091 (UMLS CUI [1,2])
C0023467 (UMLS CUI [1,3])
C0677881 (UMLS CUI [1,2])
C0278947 (UMLS CUI [2])
C0023467 (UMLS CUI [3])
C0020923 (UMLS CUI [1,2])